Cassia Cearley - Mar 7, 2022 Form 4 Insider Report for Icosavax, Inc. (ICVX)

Role
Chief Business Officer
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact for Cassia Cearley
Stock symbol
ICVX
Transactions as of
Mar 7, 2022
Transactions value $
-$171,629
Form type
4
Date filed
3/9/2022, 04:34 PM
Previous filing
Feb 14, 2022
Next filing
Mar 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Sale -$163K -9.52K -8.78% $17.13 98.9K Mar 7, 2022 Direct F1, F2
transaction ICVX Common Stock Sale -$8.62K -484 -0.49% $17.81 98.4K Mar 7, 2022 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $16.71 and $17.63. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
F3 Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $17.78 and $17.88. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.